Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Prevalence of the Mutations Responsible for Glanzmann Thrombasthenia in Horses in Brazil

Full text
Author(s):
Leite, Raissa O. [1] ; Ferreira, Julia F. [1] ; Araujo, Cesar E. T. [1] ; Delfiol, Diego J. Z. [2] ; Takahira, Regina K. [1] ; Borges, Alexandre S. [1] ; Oliveira-Filho, Jose P. [1]
Total Authors: 7
Affiliation:
[1] Sao Paulo State Univ, UNESP, Sch Vet Med & Anim Sci, Dept Vet Clin Sci, BR-18618681 Botucatu, SP - Brazil
[2] Univ Fed Uberlandia, Sch Vet Med, BR-38405320 Uberlandia, MG - Brazil
Total Affiliations: 2
Document type: Journal article
Source: ANIMALS; v. 9, n. 11 NOV 2019.
Web of Science Citations: 0
Abstract

Simple Summary Hereditary bleeding disorders occur in different species due to mutations in genes coding specific hemostatic proteins leading to alterations in their synthesis, or to the production of non-functional proteins which leads to impairment of hemostasis. Some of these disorders have been described in horses, i.e., Von Willebrand disease (VWD), hemophilia A, and Glanzmann's thrombasthenia (GT). GT is an inherited disease characterized by hemorrhage and has been described in different species including horses of varied breeds (Thoroughbred, Standardbred, Oldenburg, Peruvian Paso, and Quarter Horse). There are two different mutations described in horses a single guanine to cytosine substitution (CGG for CCG) and a 10 base pair deletion in the ITGA2B gene. Abstract Glanzmann's thrombasthenia (GT) is an autosomal recessive inherited disorder characterized by changes in platelet aggregation, leading to hemorrhage and epistaxis. To date, two independent mutations have been described in horses and associated with this disorder, a point mutation (c.122G > C) and a 10-base-pair deletion (g.1456\_1466del) in the Integrin subunit alpha2 beta gene (ITGA2B) of horses of different breeds (Quarter Horse, Thoroughbred, Oldenburg, and Peruvian Paso). ITGA2B codifies the alpha IIb subunit of the alpha IIb beta 3 integrin, also termed platelet fibrinogen receptor. Horses with GT have been diagnosed in the USA, Canada, Japan, and Australia. However, there are no studies on the prevalence of GT in horses. The aim of this study is to evaluate the prevalence of the mutations responsible for GT in horses in Brazil. A total of 1053 DNA samples of clinically healthy Quarter Horse (n = 679) and Warmblood horses (n = 374) were used. DNA fragments were amplified by PCR and sequenced. The genotype of each animal was analyzed and compared to the nucleotide sequence of the ITGA2B gene found on GenBank (TM). There were no carriers in the analyzed samples, that is, all animals tested were wild type. Therefore, under the conditions in which this study was carried out, it can be inferred that GT seems to be extremely rare in the population of Quarter Horses and Warmbloods in Brazil, although it is not possible to affirm that there are no horses carrying mutated alleles in Brazil. (AU)

FAPESP's process: 17/18757-1 - Prevalence of 10-base-pair deletion in the ITGA2B gene that causes Glanzmann Thrombastenia in Quarter Horses in Brazil
Grantee:Julia Franco Ferreira
Support Opportunities: Scholarships in Brazil - Scientific Initiation